Our results showed that knockdown of TRF2 in gastric cancer cells resulted in the downregulation of SLC7A11 and GPX4 expressions at the mRNA and protein levels, while the expression of SLC7A11 and GPX4 recovered after pretreatment with the ferroptosis inhibitor ferrostatin-1. Here, SLC7A11 is linked to gastric cancer.